Crossref
Efficacy of intravitreal bevacizumab monotherapy in the treatment of retinopathy of prematurity
Journal of Retina-Vitreous · 2020
DOI: 10.37845/ret.vit.2020.29.36 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Retina-Vitreous, 2020. Verfasst von Caner KARA und 4 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
KARA, C., PETRICLI, I. S., ARMAN, A., OZCAN, C., & IYIGUN, F. (2020). Efficacy of intravitreal bevacizumab monotherapy in the treatment of retinopathy of prematurity. Journal of Retina-Vitreous. https://doi.org/10.37845/ret.vit.2020.29.36
Vancouver
KARA C, PETRICLI IS, ARMAN A, OZCAN C, IYIGUN F. Efficacy of intravitreal bevacizumab monotherapy in the treatment of retinopathy of prematurity. Journal of Retina-Vitreous. 2020. doi:10.37845/ret.vit.2020.29.36
BibTeX
@article{KARA2020,
author = {KARA, Caner and PETRICLI, Ikbal Seza and ARMAN, Aysegul and OZCAN, Cagatay and IYIGUN, Fatma},
title = {Efficacy of intravitreal bevacizumab monotherapy in the treatment of retinopathy of prematurity},
journal = {Journal of Retina-Vitreous},
year = {2020},
doi = {10.37845/ret.vit.2020.29.36}
}
EUVIMED